Human mesenchymal stem cells inhibit endothelial proliferation and angiogenesis via cell-cell contact through modulation of the VE-Cadherin/β-catenin signaling pathway

Stem Cells and Development

Volumn 22, Issue 1, 2013, Pages 148-157

  Menge, Tyler ^a   Gerber, Michael ^b   Wataha, Kathryn ^a   Reid, William ^c   Guha, Sushovan ^d   Cox, Charles S ^e   Dash, Pramod ^e   Reitz, Marvin S ^f   Khakoo, Aarif Y ^g   Pati, Shibani ^a,h  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f UNIVERSITY OF MARYLAND   (United States)

^g AMGEN INC   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CELL MEMBRANE PROTEIN; MATRIGEL; VASCULAR ENDOTHELIAL CADHERIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL COMMUNICATION; CELL INTERACTION; CELL PROLIFERATION; CELL TYPE; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MESENCHYMAL STEM CELL; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ADHERENS JUNCTIONS; ANIMALS; ANTIGENS, CD; BETA CATENIN; CADHERINS; CELL COMMUNICATION; CELL PROLIFERATION; COCULTURE TECHNIQUES; COLLAGEN; DRUG COMBINATIONS; G1 PHASE CELL CYCLE CHECKPOINTS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LAMININ; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; WNT SIGNALING PATHWAY; WNT3A PROTEIN;

EID: 84871436815     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0165     Document Type: Article

References (25)

1. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147. (Pubitemid 29282067)
2. Khakoo AY, S Pati, SA Anderson, W Reid, MF Elshal, II Rovira, AT Nguyen, D Malide, CA Combs, et al. (2006). Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 203:1235-1247. (Pubitemid 43736593)
3. Uccelli A, L Moretta and V Pistoia. (2008). Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726-736.
4. Nemeth K, A Leelahavanichkul, PS Yuen, B Mayer, A Parmelee, K Doi, PG Robey, K Leelahavanichkul, BH Koller, et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42-49.
5. Qian H, H Yang, W Xu, Y Yan, Q Chen, W Zhu, H Cao, Q Yin, H Zhou, F Mao and Y Chen. (2008). Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells. Int J Mol Med 22:325-332.
6. Le Blanc K, I Rasmusson, B Sundberg, C Gotherstrom, M Hassan, M Uzunel and O Ringden. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439- 1441. (Pubitemid 38586721)
7. Gupta N, X Su, B Popov, JW Lee, V Serikov and MA Matthay. (2007). Intrapulmonary delivery of bone marrowderived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice. J Immunol 179:1855-1863.
8. Amado LC, AP Saliaris, KH Schuleri, M St John, JS Xie, S Cattaneo, DJ Durand, T Fitton, JQ Kuang, et al. (2005).Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci (U S A) 102:11474-11479. (Pubitemid 41153844)
9. Pati S, M Cavrois, HG Guo, JS Foulke Jr, J Kim, RA Feldman and M Reitz. (2001). Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J Virol 75:8660-8673. (Pubitemid 32768970)
10. Walker PA, SK Shah, F Jimenez, MH Gerber, H Xue, R Cutrone, JA Hamilton, RW Mays, R Deans, et al. (2010). Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes. Exp Neurol 225:341-352.
11. Pati S, AY Khakoo, J Zhao, F Jimenez, MH Gerber, M Harting, JB Redell, R Grill, Y Matsuo, et al. (2011). Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/beta-catenin signaling. Stem Cells Dev 20:89-101.
12. Nagaya N, T Fujii, T Iwase, H Ohgushi, T Itoh, M Uematsu, M Yamagishi, H Mori, K Kangawa and S Kitamura. (2004). Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 287:H2670-H2676. (Pubitemid 39557139)
13. Otsu K, S Das, SD Houser, SK Quadri, S Bhattacharya and J Bhattacharya. (2009). Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood 113:4197- 4205.
14. Kim SW, H Han, GT Chae, SH Lee, S Bo, JH Yoon, YS Lee, KS Lee, HK Park and KS Kang. (2006). Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 24:1620-1626. (Pubitemid 44464680)
15. Kinnaird T, E Stabile, MS Burnett, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678-685. (Pubitemid 38387752)
16. Kinnaird T, E Stabile, MS Burnett, M Shou, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Local delivery of marrowderived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109:1543-1549. (Pubitemid 38420184)
17. Kidd S, E Spaeth, A Klopp, M Andreeff, B Hall and FC Marini. (2008). The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy 10:657-667.
18. Sun B, KH Roh, JR Park, SR Lee, SB park, JW Jung, SK Kang, YS Lee and KS Kang. (2009). Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model. Cytotherapy 11:289-298.
19. Halkos ME, ZQ Zhao, F Kerendi, NP Wang, R Jiang, LS Schmarkey, BJ Martin, AA Quyyumi, WL Few, et al. (2008). Intravenous infusion of mesenchymal stem cells enhances regional perfusion and improves ventricular function in a porcine model of myocardial infarction. Basic Res Cardiol 103:525-536.
20. Au P, J Tam, D Fukumura and RK Jain. (2008). Bone marrow- derived mesenchymal stem cells facilitate engineeringof long-lasting functional vasculature. Blood 111:4551-4558.
21. Pati S, MH Gerber, TD Menge, KA Wataha, Y Zhao, JA Baumgartner, J Zhao, PA Letourneau, MP Huby, et al. (2011). Bone marrow derived mesenchymal stem cells inhibit inflammation and preserve vascular endothelial integrity in the lungs after hemorrhagic shock. PLoS One 6:e25171.
22. Fischer UM, MT Hartin, F Jimenez, WO Monzon-Posadas, H Xue, SI Savitz, GA Laine and CS Cox Jr. (2009). Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18:683- 692.
23. Block GJ, S Ohkouchi, F Fung, J Frenkel, C Gregory, R Pochampally, G Dimattia, DE Sullivan and DJ Prockop. (2009). Multipotent stromal cells (mscs) are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin- 1 (STC-1). Stem Cells 27:670-681.
24. Lee RH, AA Pulin, MJ Seo, DJ Kota, J Ylostalo, BL Larson, L Semprun-Prieto, P Delafontaine and DJ Prockop. (2009).Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5:54-63.
25. Fang X, AP Neyrinck, MA Matthay and JW Lee. (2010). Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1. J Biol Chem 285:26211- 26222.